TR201911328T4 - İlaç, organik çözücü, lipofilik merhem bazı ve tozun harmanlanmasıyla elde edilen yapıştırıcı preparasyon bileşimi. - Google Patents
İlaç, organik çözücü, lipofilik merhem bazı ve tozun harmanlanmasıyla elde edilen yapıştırıcı preparasyon bileşimi. Download PDFInfo
- Publication number
- TR201911328T4 TR201911328T4 TR2019/11328T TR201911328T TR201911328T4 TR 201911328 T4 TR201911328 T4 TR 201911328T4 TR 2019/11328 T TR2019/11328 T TR 2019/11328T TR 201911328 T TR201911328 T TR 201911328T TR 201911328 T4 TR201911328 T4 TR 201911328T4
- Authority
- TR
- Turkey
- Prior art keywords
- drug
- organic solvent
- patch preparation
- powder
- composition obtained
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 8
- 239000000203 mixture Substances 0.000 title abstract 3
- 239000003960 organic solvent Substances 0.000 title abstract 3
- 239000000843 powder Substances 0.000 title abstract 3
- 239000000853 adhesive Substances 0.000 title 1
- 230000001070 adhesive effect Effects 0.000 title 1
- 238000002156 mixing Methods 0.000 title 1
- 239000003883 ointment base Substances 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 7
- 229940079593 drug Drugs 0.000 abstract 7
- 238000013268 sustained release Methods 0.000 abstract 2
- 239000012730 sustained-release form Substances 0.000 abstract 2
- 239000000945 filler Substances 0.000 abstract 1
- 239000002608 ionic liquid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012139215 | 2012-06-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201911328T4 true TR201911328T4 (tr) | 2019-08-21 |
Family
ID=49768781
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2019/11328T TR201911328T4 (tr) | 2012-06-20 | 2013-06-18 | İlaç, organik çözücü, lipofilik merhem bazı ve tozun harmanlanmasıyla elde edilen yapıştırıcı preparasyon bileşimi. |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US10543275B2 (OSRAM) |
| EP (1) | EP2865376B2 (OSRAM) |
| JP (1) | JP6309892B2 (OSRAM) |
| CN (3) | CN110693859A (OSRAM) |
| AU (1) | AU2013278403B2 (OSRAM) |
| BR (1) | BR112014031701A2 (OSRAM) |
| CA (1) | CA2875454C (OSRAM) |
| DK (1) | DK2865376T4 (OSRAM) |
| ES (1) | ES2738303T5 (OSRAM) |
| HU (1) | HUE045479T2 (OSRAM) |
| IN (1) | IN2014DN10706A (OSRAM) |
| PL (1) | PL2865376T5 (OSRAM) |
| PT (1) | PT2865376T (OSRAM) |
| SI (1) | SI2865376T1 (OSRAM) |
| TR (1) | TR201911328T4 (OSRAM) |
| WO (1) | WO2013191187A1 (OSRAM) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015037639A1 (ja) | 2013-09-11 | 2015-03-19 | 株式会社 メドレックス | テープ剤の新規な基剤組成物 |
| CN103830206B (zh) * | 2014-02-26 | 2016-08-31 | 上海现代药物制剂工程研究中心有限公司 | 阿戈美拉汀三维网状立体构型的透皮给药制剂及制备方法 |
| US10045948B2 (en) | 2014-02-27 | 2018-08-14 | Medrx Co., Ltd. | Pramipexole-containing transdermal patch for treatment of neurodegenerative disease |
| WO2016109483A1 (en) * | 2014-12-30 | 2016-07-07 | Noven Pharmaceuticals, Inc. | Transdermal drug delivery systems for agomelatine |
| WO2017037812A1 (ja) * | 2015-08-29 | 2017-03-09 | 株式会社メドレックス | 酸捕捉剤を含有する貼付製剤 |
| US10016502B2 (en) | 2015-08-29 | 2018-07-10 | Medrx Co., Ltd | Patch preparation containing an acid scavenger |
| WO2017037813A1 (ja) * | 2015-08-29 | 2017-03-09 | 株式会社メドレックス | 塩基性薬物とソルビン酸とを含有する経皮吸収組成物 |
| US20170273974A1 (en) | 2016-03-24 | 2017-09-28 | Medrx Co., Ltd | Patch preparations with misuse prevention features |
| ES2957234T3 (es) * | 2016-03-24 | 2024-01-15 | Medrx Co Ltd | Preparación de parche con características de prevención del uso incorrecto de sustancias |
| JP7143219B2 (ja) * | 2016-11-09 | 2022-09-28 | 株式会社クラレ | 粘着シート、絆創膏及びこれらの製造方法 |
| CN113164423A (zh) * | 2018-10-04 | 2021-07-23 | 美德阿利克斯株式会社 | 用非水溶剂稳定化的制剂 |
| JPWO2022173006A1 (OSRAM) * | 2021-02-12 | 2022-08-18 | ||
| JP7179212B1 (ja) | 2022-05-02 | 2022-11-28 | 久光製薬株式会社 | リドカイン含有貼付剤 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3144895B2 (ja) * | 1992-06-30 | 2001-03-12 | 積水化学工業株式会社 | 医療用粘着テープもしくはシート |
| JPH06145050A (ja) | 1992-11-11 | 1994-05-24 | Sekisui Chem Co Ltd | 貼付剤の製造方法 |
| JPH07145047A (ja) | 1993-11-25 | 1995-06-06 | Sekisui Chem Co Ltd | 局所麻酔用経皮吸収テープ |
| JPH0827003A (ja) † | 1994-07-22 | 1996-01-30 | Sekisui Chem Co Ltd | 経皮吸収製剤 |
| JPH09169636A (ja) | 1995-06-12 | 1997-06-30 | Sekisui Chem Co Ltd | 貼付剤 |
| JPH09136834A (ja) | 1995-11-14 | 1997-05-27 | Sekisui Chem Co Ltd | 経皮吸収貼付剤 |
| JP4648518B2 (ja) * | 2000-06-01 | 2011-03-09 | 帝國製薬株式会社 | ４−ビフェニル酢酸含有貼付剤 |
| DE10033853A1 (de) † | 2000-07-12 | 2002-01-31 | Hexal Ag | Transdermales therapeutisches System mit hochdispersem Siliziumdioxid |
| US6503532B1 (en) * | 2001-04-13 | 2003-01-07 | Murty Pharmaceuticals, Inc. | Pharmaceutical composition containing tetrahydrocannabinol and a transdermal/transcutaneous delivery method thereof |
| US7785622B2 (en) * | 2002-09-13 | 2010-08-31 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive patch for fentanyl administration |
| KR20050092429A (ko) * | 2003-01-22 | 2005-09-21 | 니찌방 가부시기가이샤 | 안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환치료약의 눈의 국소 조직으로의 이행 방법 |
| US8080261B2 (en) * | 2004-09-30 | 2011-12-20 | Teikoku Pharma Usa, Inc. | 1-chloro-2,4-dinitrobenzene non-aqueous gel compositions and methods for using the same |
| KR101426364B1 (ko) * | 2006-09-11 | 2014-08-05 | 세키스이가가쿠 고교가부시키가이샤 | 첩부제 |
| WO2008032719A1 (en) | 2006-09-11 | 2008-03-20 | Sekisui Chemical Co., Ltd. | Adhesive preparation |
| AU2008327436B2 (en) * | 2007-11-22 | 2013-09-05 | Medrx Co., Ltd. | External preparation composition comprising fatty acid-based ionic liquid as active ingredient |
| WO2009110351A1 (ja) | 2008-03-03 | 2009-09-11 | 久光製薬株式会社 | 経皮吸収製剤 |
| JP4822032B2 (ja) | 2009-01-08 | 2011-11-24 | タイヨーエレック株式会社 | 組合せ式遊技機 |
| WO2010113225A1 (en) * | 2009-03-30 | 2010-10-07 | Yutoku Pharmaceutical Industries Co., Ltd. | Riluzole-containing transdermal patch |
| DE102009022915A1 (de) * | 2009-05-27 | 2010-12-09 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System mit gesteuertem Wirkstofffluss |
| JP2011074035A (ja) | 2009-09-30 | 2011-04-14 | Sekisui Medical Co Ltd | 貼付剤 |
-
2013
- 2013-06-18 PL PL13806076.9T patent/PL2865376T5/pl unknown
- 2013-06-18 CN CN201911053677.0A patent/CN110693859A/zh active Pending
- 2013-06-18 ES ES13806076T patent/ES2738303T5/es active Active
- 2013-06-18 WO PCT/JP2013/066765 patent/WO2013191187A1/ja not_active Ceased
- 2013-06-18 DK DK13806076.9T patent/DK2865376T4/da active
- 2013-06-18 SI SI201331532T patent/SI2865376T1/sl unknown
- 2013-06-18 JP JP2014521482A patent/JP6309892B2/ja active Active
- 2013-06-18 HU HUE13806076A patent/HUE045479T2/hu unknown
- 2013-06-18 PT PT13806076T patent/PT2865376T/pt unknown
- 2013-06-18 TR TR2019/11328T patent/TR201911328T4/tr unknown
- 2013-06-18 CA CA2875454A patent/CA2875454C/en active Active
- 2013-06-18 EP EP13806076.9A patent/EP2865376B2/en active Active
- 2013-06-18 CN CN201810750500.5A patent/CN108553452A/zh active Pending
- 2013-06-18 CN CN201380031729.9A patent/CN104363900A/zh active Pending
- 2013-06-18 IN IN10706DEN2014 patent/IN2014DN10706A/en unknown
- 2013-06-18 US US14/408,649 patent/US10543275B2/en active Active
- 2013-06-18 AU AU2013278403A patent/AU2013278403B2/en not_active Ceased
- 2013-06-18 BR BR112014031701A patent/BR112014031701A2/pt not_active Application Discontinuation
-
2019
- 2019-09-09 US US16/564,587 patent/US12016924B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2013278403B2 (en) | 2018-02-01 |
| JP6309892B2 (ja) | 2018-04-11 |
| US20150174249A1 (en) | 2015-06-25 |
| PL2865376T3 (pl) | 2019-12-31 |
| SI2865376T1 (sl) | 2019-11-29 |
| PT2865376T (pt) | 2019-08-26 |
| JPWO2013191187A1 (ja) | 2016-05-26 |
| EP2865376A1 (en) | 2015-04-29 |
| BR112014031701A2 (pt) | 2017-06-27 |
| WO2013191187A1 (ja) | 2013-12-27 |
| EP2865376B1 (en) | 2019-06-05 |
| DK2865376T3 (da) | 2019-08-12 |
| US10543275B2 (en) | 2020-01-28 |
| CN110693859A (zh) | 2020-01-17 |
| EP2865376B2 (en) | 2022-05-11 |
| HUE045479T2 (hu) | 2019-12-30 |
| IN2014DN10706A (OSRAM) | 2015-09-04 |
| CA2875454C (en) | 2021-02-16 |
| CA2875454A1 (en) | 2013-12-27 |
| ES2738303T5 (es) | 2022-09-12 |
| EP2865376A4 (en) | 2015-11-18 |
| CN104363900A (zh) | 2015-02-18 |
| ES2738303T3 (es) | 2020-01-21 |
| CN108553452A (zh) | 2018-09-21 |
| PL2865376T5 (pl) | 2023-01-09 |
| AU2013278403A1 (en) | 2015-01-22 |
| DK2865376T4 (da) | 2022-07-18 |
| US20190388544A1 (en) | 2019-12-26 |
| US12016924B2 (en) | 2024-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR201911328T4 (tr) | İlaç, organik çözücü, lipofilik merhem bazı ve tozun harmanlanmasıyla elde edilen yapıştırıcı preparasyon bileşimi. | |
| CY1120521T1 (el) | Παρασκευασμα προμειγματος δεξμεδετομιδινης | |
| GT201200334A (es) | Morfolinopirimidinas y su uso en terapia | |
| MX2023008779A (es) | Adenovirus armado con un activador biespecifico de linfocitos t. | |
| DK2811981T3 (da) | Forbedrede adjuvansformuleringer, der omfatter tlr4-agonister, og fremgangsmåder til anvendelse heraf | |
| CO6640311A2 (es) | Compuestos, composiciones de tioacetato y métodos de uso | |
| CR20120634A (es) | Derivados de heteroaril imidazolona como inhibidores de jak | |
| CL2010001475A1 (es) | Compuestos derivados de ester boronato, inhibidores de proteasoma; composiciones farmaceuticas que los contienen; procedimiento de preparacion de la composición farmaceutica; utiles en el tratamiento de enfermedades proliferativas celulares, en particular cancer. | |
| CO6670585A2 (es) | Promotores de apotosis n-acilsufonamidas | |
| EA201391059A1 (ru) | Композиции для лечения рака и способы их применения | |
| PH12014502441A1 (en) | Topical non-aqueous pharmaceutical formulations | |
| CR20150175A (es) | Derivados de pirrolotriazinona como inhibidores de pi3k | |
| EA201390090A1 (ru) | Дезинфицирующий и антисептический препарат, имеющий сниженное содержание йода | |
| MX2014005353A (es) | Procedimiento para la preparacion de un complejo polipeptidico fisiologicamente activo. | |
| MA38430A1 (fr) | Compositions pharmaceutiques comprenant de l'évérolimus | |
| DOP2015000145A (es) | NUEVOS DERIVADOS CARBAMATO DE CICLOHEXILO Y QUINUCLIDINILO QUE TIENEN ACTIVIDAD COMO AGONISTAS ß2 ADRENÉRGICOS Y COMO ANTAGONISTAS MUSCARÍNICOS M3 | |
| CO7240370A2 (es) | Forma farmaceútica para la liberación prolongada de sustancias activas | |
| BR112014014212A2 (pt) | composições contendo película | |
| EA201590269A1 (ru) | Трансдермальный препарат, содержащий ингибиторы cox | |
| BR112013017570A2 (pt) | compostos de pirazola como antagonistas de crth2 | |
| IN2014DN09830A (OSRAM) | ||
| EA201390980A1 (ru) | Лекарственный пластырь для улучшенного трансдермального проникновения диклофенака диэтиламмония | |
| CY1122538T1 (el) | Συμπλεγματα χονδροϊτινης για διαδερμικη απορροφηση | |
| MX359436B (es) | Preparacion de combinacion farmaceutica que comprende un inhibidor de hmg-coa reductasa y un inhibidor de la absorcion de colesterol. | |
| CL2014002115A1 (es) | Solución oxidante que contiene una mezcla de oxidante disuelto para la preparacion de formulaciones de explosivos; formulacion de explosivos. |